Microfluidic Screening of Virus-Producing Cells With In Situ Caps
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing viral vectors are inefficient in screening virus-producing cells for desired productivity, leading to high manufacturing costs and dosage requirements.
Innovation Solution
A microfluidic device is used to preserve and evaluate virus-producing cells by forming in situ-generated caps in specific chambers to block passage, allowing for the evaluation of viral particle productivity and efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used for producing viral vectors, then the production process is simple, but the screening efficiency of virus-producing cells is low and manufacturing costs are high
Solution Approach 1:
The invention divides the production and screening process into distinct functional modules: virus-producing cell culture chambers, microfluidic flow channels for reagent delivery, and detection zones for productivity assessment. This segmentation allows simultaneous cultivation and evaluation of multiple cell lines, dramatically improving screening efficiency while maintaining manageable system complexity through modular design
Solution Approach 2:
The microfluidic device integrates multiple functions into a single platform: cell culture, viral particle production, productivity evaluation, and data collection. This multi-functionality eliminates the need for separate conventional processes for each step, improving overall productivity without proportionally increasing device complexity
2Ease of manufacture
If conventional production methods are used, then the manufacturing process is straightforward, but the manufacturing costs and dosage requirements are high
Solution Approach 1:
The system automatically performs productivity evaluation by collecting data from virus-producing cells within the microfluidic device. The integrated detection mechanisms autonomously assess viral particle production without requiring manual intervention for each measurement, maintaining ease of manufacture while significantly improving productivity through continuous monitoring and automated data collection
Solution Approach 2:
The device incorporates real-time feedback mechanisms that monitor productivity metrics of virus-producing cells during cultivation. This feedback enables dynamic optimization of production conditions, allowing the system to maintain high productivity while preserving ease of manufacture through automated control rather than complex manual adjustments
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively screens and evaluates virus-producing cells, reducing manufacturing costs and optimizing viral vector production.
Implementation Method 1
forming a first in situ-generated cap within the preserving chamber, wherein the first in situ-generated cap comprises a porosity to selectively block passage between the preserving chamber and the flow region
Data Source
AI summary
Method of evaluating a virus-producing cell on a microfluidic device is described therein. The method comprises culturing the virus-producing cell thereby producing a viral particle in a chamber of the microfluidic device; and evaluating a productivity of the virus-producing cell in producing the viral particle. Additionally, method for preserving a subset of biological micro-objects within a microfluidic device is also described herein so that the subset of biological micro-objects can be protected from being affected by the assays performed on the microfluidic device.